Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: A Multidisciplinary Team-based, Multifactorial Analytical Approach.

Johnston SK, Whitmire P, Massey SC, Kumthekar P, Porter AB, Raghunand N, Gonzalez-Cuyar LF, Mrugala MM, Hawkins-Daarud A, Jackson PR, Hu LS, Sarkaria JN, Wang L, Gatenby RA, Egan KM, Canoll P, Swanson KR; ENDURES consortium.

Am J Clin Oncol. 2019 Aug;42(8):655-661. doi: 10.1097/COC.0000000000000564.

PMID:
31343422
2.

Improved model prediction of glioma growth utilizing tissue-specific boundary effects.

Jacobs J, Rockne RC, Hawkins-Daarud AJ, Jackson PR, Johnston SK, Kinahan P, Swanson KR.

Math Biosci. 2019 Jun;312:59-66. doi: 10.1016/j.mbs.2019.04.004. Epub 2019 Apr 19.

PMID:
31009624
3.

Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme.

Stringfield O, Arrington JA, Johnston SK, Rognin NG, Peeri NC, Balagurunathan Y, Jackson PR, Clark-Swanson KR, Swanson KR, Egan KM, Gatenby RA, Raghunand N.

Tomography. 2019 Mar;5(1):135-144. doi: 10.18383/j.tom.2018.00052.

4.

Characterization of all-terrain vehicle-related chest injury patterns in children.

Hagedorn KN, Johnston JH, Chinapuvvula NR, Beckmann NM, Cai C, Johnston SK.

Emerg Radiol. 2019 Aug;26(4):373-379. doi: 10.1007/s10140-019-01679-y. Epub 2019 Feb 21.

PMID:
30790115
5.

Quantifying Uncertainty and Robustness in a Biomathematical Model-Based Patient-Specific Response Metric for Glioblastoma.

Hawkins-Daarud A, Johnston SK, Swanson KR.

JCO Clin Cancer Inform. 2019 Feb;3:1-8. doi: 10.1200/CCI.18.00066.

6.

Determinants of assessing efficiency within auditory attention networks.

Johnston SK, Hennessey NW, Leitão S.

J Gen Psychol. 2019 Apr-Jun;146(2):134-169. doi: 10.1080/00221309.2018.1541861. Epub 2019 Jan 19.

PMID:
30663526
7.

Distinct Phenotypic Clusters of Glioblastoma Growth and Response Kinetics Predict Survival.

Rayfield CA, Grady F, De Leon G, Rockne R, Carrasco E, Jackson P, Vora M, Johnston SK, Hawkins-Daarud A, Clark-Swanson KR, Whitmire S, Gamez ME, Porter A, Hu L, Gonzalez-Cuyar L, Bendok B, Vora S, Swanson KR.

JCO Clin Cancer Inform. 2018 Dec;2:1-14. doi: 10.1200/CCI.17.00080.

8.

Letter: Surgical Decision Making From Image-Based Biophysical Modeling of Glioblastoma: Not Ready for Primetime.

Massey SC, Johnston SK, Canoll PD, Bruce JN, Bendok BR, Swanson KR.

Neurosurgery. 2018 Jan 1;82(1):E17-E18. doi: 10.1093/neuros/nyx481. No abstract available.

PMID:
29029349
9.

Hands-Free Phone Calls Impair Visual Performance.

Rabin JC, Bradshaw TL, Chacon AM, Johnston SK, Yu DB.

Am J Prev Med. 2016 Oct;51(4):e117-8. doi: 10.1016/j.amepre.2016.05.006. Epub 2016 Jun 15. No abstract available.

PMID:
27316773
10.

Particles at Oil-Air Surfaces: Powdered Oil, Liquid Oil Marbles, and Oil Foam.

Binks BP, Johnston SK, Sekine T, Tyowua AT.

ACS Appl Mater Interfaces. 2015 Jul 8;7(26):14328-37. doi: 10.1021/acsami.5b02890. Epub 2015 Jun 24.

PMID:
26107421
11.

Response to "Tumor cells in search for glutamate: an alternative explanation for increased invasiveness of IDH1 mutant gliomas".

Trister A, Scott J, Rockne R, Yagle K, Johnston SK, Hawkins-Daarud A, Baldock A, Swanson KR.

Neuro Oncol. 2014 Dec;16(12):1670-1. doi: 10.1093/neuonc/nou290. No abstract available.

12.

Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients.

Adair JE, Johnston SK, Mrugala MM, Beard BC, Guyman LA, Baldock AL, Bridge CA, Hawkins-Daarud A, Gori JL, Born DE, Gonzalez-Cuyar LF, Silbergeld DL, Rockne RC, Storer BE, Rockhill JK, Swanson KR, Kiem HP.

J Clin Invest. 2014 Sep;124(9):4082-92. doi: 10.1172/JCI76739. Epub 2014 Aug 8.

13.

Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status.

Baldock AL, Yagle K, Born DE, Ahn S, Trister AD, Neal M, Johnston SK, Bridge CA, Basanta D, Scott J, Malone H, Sonabend AM, Canoll P, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR.

Neuro Oncol. 2014 Jun;16(6):779-86. doi: 10.1093/neuonc/nou027.

14.

A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.

Raizer JJ, Grimm SA, Rademaker A, Chandler JP, Muro K, Helenowski I, Rice L, McCarthy K, Johnston SK, Mrugala MM, Chamberlain M.

J Neurooncol. 2014 Mar;117(1):93-101. doi: 10.1007/s11060-014-1358-9. Epub 2014 Jan 22.

PMID:
24449400
15.

Salvage therapy with single agent bendamustine for recurrent glioblastoma.

Chamberlain MC, Johnston SK.

J Neurooncol. 2011 Dec;105(3):523-30. doi: 10.1007/s11060-011-0612-7. Epub 2011 May 29.

PMID:
21626071
16.

Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series.

Chamberlain MC, Johnston SK.

J Neurooncol. 2011 Sep;104(3):765-71. doi: 10.1007/s11060-011-0541-5. Epub 2011 Feb 13.

PMID:
21318318
17.

Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab.

Chamberlain MC, Johnston SK.

J Neurooncol. 2011 May;102(3):427-32. doi: 10.1007/s11060-010-0330-6. Epub 2010 Aug 1.

PMID:
20680397
18.

High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma.

Chamberlain MC, Johnston SK.

Neuro Oncol. 2010 Jul;12(7):736-44. doi: 10.1093/neuonc/noq011. Epub 2010 Feb 8.

19.

Salvage therapy with single agent bevacizumab for recurrent glioblastoma.

Chamberlain MC, Johnston SK.

J Neurooncol. 2010 Jan;96(2):259-69. doi: 10.1007/s11060-009-9957-6. Epub 2009 Jul 11.

PMID:
19593660
20.

Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma.

Chamberlain MC, Johnston SK.

Cancer. 2009 Oct 15;115(20):4775-82. doi: 10.1002/cncr.24524.

21.

Designing and testing a web-based interface for self-monitoring of exercise and symptoms for older adults with chronic obstructive pulmonary disease.

Johnston SK, Nguyen HQ, Wolpin S.

Comput Inform Nurs. 2009 May-Jun;27(3):166-74. doi: 10.1097/NCN.0b013e31819f7c1d.

22.

Neoplastic meningitis: survival as a function of cerebrospinal fluid cytology.

Chamberlain MC, Johnston SK.

Cancer. 2009 May 1;115(9):1941-6. doi: 10.1002/cncr.24210.

23.

Neoplastic meningitis-related prognostic significance of the Karnofsky performance status.

Chamberlain MC, Johnston SK, Glantz MJ.

Arch Neurol. 2009 Jan;66(1):74-8. doi: 10.1001/archneurol.2008.506.

PMID:
19139302
24.

Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C.

Chamberlain MC, Johnston SK, Van Horn A, Glantz MJ.

J Neurooncol. 2009 Feb;91(3):271-7. doi: 10.1007/s11060-008-9707-1. Epub 2008 Sep 27.

PMID:
18820836
26.

Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach.

Parker JC, Smarr KL, Slaughter JR, Johnston SK, Priesmeyer ML, Hanson KD, Johnson GE, Hewett JE, Hewett JE, Irvin WS, Komatireddy GR, Walker SE.

Arthritis Rheum. 2003 Dec 15;49(6):766-77.

27.

Natural killer cell cytotoxicity: a methods analysis of 51chromium release versus flow cytometry.

Motzer SA, Tsuji J, Hertig V, Johnston SK, Scanlan J.

Biol Res Nurs. 2003 Oct;5(2):142-52.

PMID:
14531218
28.

Stress exposure, psychological distress, and physiological stress activation in midlife women with insomnia.

Shaver JL, Johnston SK, Lentz MJ, Landis CA.

Psychosom Med. 2002 Sep-Oct;64(5):793-802.

PMID:
12271110
29.

Self-reported nap behavior and polysomnography at home in midlife women with and without insomnia.

Johnston SK, Landis CA, Lentz MJ, Shaver JL.

Sleep. 2001 Dec 15;24(8):913-9.

PMID:
11766161
30.

Restraint reduction: a new philosophy for a new millennium.

Jensen B, Hess-Zak A, Johnston SK, Otto DC, Tebbe L, Russell CL, Waller AS.

J Nurs Adm. 1998 Jul-Aug;28(7-8):32-8.

PMID:
9709694
31.

Just-in-time: maximizing its success potential.

Johnston SK.

Hosp Mater Manage Q. 1990 Aug;12(1):22-9.

PMID:
10105557

Supplemental Content

Loading ...
Support Center